Issues related to COVID-19 vaccines Reauthorization of Pandemic and All-Hazards Preparedness Act General discussions related to vaccine injury compensation programs and vaccine strain selection timelines.
Source-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 28, 2025
- Income
- Not reported
- Expenses
- $170,000.00
- Registrant
- NOVAVAX, INC
- Client
- NOVAVAX, INC
- Filing UUID
- 7a364f79-6d2d-481c-ae8f-c5ecd44f539b
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.